Literature DB >> 23910609

Clinical characteristics of systemic sclerosis patients with digital ulcers in China.

Dong Xu1, Meng-Tao Li, Yong Hou, Qian Wang, Chao-Jun Hu, Ning Song, Jiu-Liang Zhao, Xiao-Feng Zeng, Feng-Chun Zhang.   

Abstract

OBJECTIVES: To investigate the clinical characteristics of SSc patients with DUs in China.
METHODS: The data of 267 consecutive SSc patients based on the EUSTAR DATABASE from Peking Union Medical College Hospital from February 2009 to March 2012 were prospectively collected. The patients with DUs were compared to those without DUs.
RESULTS: Seventy-nine patients (29.6%) had DUs out of 267 SSc patients analysed. There were significant differences between patients with and without DU based on sex (female/male: 65/14 vs. 174/14), age of onset of SSc (32.3±11.7 vs. 40.4±12.6 y), age of onset of Raynaud's phenomenon (31.8±12.3 vs. 38.7±12.2) (p<0.05). In addition, there was a higher rate of diffuse SSc, gastrointestinal involvement, (especially esophageal involvement), and pericardial effusion, higher mRodnan score, and more anti-scl70 antibody positivity in patients with DU (p<0.05). A multivariate analysis identified anti-Scl70 antibody positivity, gastrointestinal involvement and a younger age at disease onset as three risk factors for developing DUs in SSc patients.
CONCLUSIONS: The occurrence of DUs in Chinese SSc patients is frequent. It is possible that SSc patients with DUs were influenced by the disease earlier in life, which should be detected early for effective intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23910609

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Authors:  Jelena Blagojevic; G Abignano; J Avouac; L Cometi; M Frerix; S Bellando-Randone; S Guiducci; C Bruni; D Huscher; V K Jaeger; V Lóránd; B Maurer; S Nihtyanova; G Riemekasten; E Siegert; I H Tarner; S Vettori; U A Walker; L Czirják; C P Denton; O Distler; Y Allanore; U Müller-Ladner; A Moggi-Pignone; M Matucci-Cerinic; F Del Galdo
Journal:  Clin Rheumatol       Date:  2019-05-20       Impact factor: 2.980

2.  Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry.

Authors:  Marco Matucci-Cerinic; Thomas Krieg; Loic Guillevin; Barbara Schwierin; Daniel Rosenberg; Peter Cornelisse; Christopher P Denton
Journal:  Ann Rheum Dis       Date:  2015-11-26       Impact factor: 19.103

3.  Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.

Authors:  Shasha Hu; Yong Hou; Qian Wang; Mengtao Li; Dong Xu; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2018-10-22       Impact factor: 5.156

4.  Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets.

Authors:  Pia Moinzadeh; Kathrin Kuhr; Elise Siegert; Ulf Mueller-Ladner; Gabriela Riemekasten; Claudia Günther; Ina Kötter; Jörg Henes; Norbert Blank; Gabriele Zeidler; Christiane Pfeiffer; Aaron Juche; Ilona Jandova; Jan Ehrchen; Marc Schmalzing; Laura Susok; Tim Schmeiser; Cord Sunderkoetter; Jörg H W Distler; Margitta Worm; Alexander Kreuter; Thomas Krieg; Nicolas Hunzelmann
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.